Cell Therapy Market to Surpass US$ 54.6 Bn by 2032, Latest Study by TMR
The latest analysis report on the ๐๐๐ฅ๐ฅ ๐ญ๐ก๐๐ซ๐๐ฉ๐ฒ ๐ฆ๐๐ซ๐ค๐๐ญ, recently published by Transparency Market Research, reveals that global sales reached US$ 8.5 billion in 2021. Projections indicate a remarkable growth trajectory, with an anticipated market expansion of 18.7% to attain US$ 54.6 Bn from 2022 to 2032, surpassing historical growth rates. Among the segments, autologous therapies are forecasted to emerge as the leading revenue generator, with an expected Compound Annual Growth Rate (CAGR) exceeding 18% from 2022 to 2032.๐๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63273&utm_source=OpenPR&utm_campaign=MansiR_OpenPR
๐๐ก๐๐ญ ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ ๐๐ซ๐จ๐ฉ๐๐ฅ๐ฅ๐ข๐ง๐ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ฆ๐๐ง๐?
Cell and gene therapies (CGTs) represent cutting-edge technology for treating severe and rare diseases.
LUXTURNA, a therapy targeting a hereditary retinal illness causing blindness, is among several such treatments available.
CGT signifies a significant medical advancement, notably as the first curative gene therapy approved for use.
In August 2020, the FDA approved Novartis' Kymriah for refractory follicular lymphoma, marking a milestone in regenerative medicine.
July 2020 saw FDA approval for brexucabtagene Acelus, a CAR T-cell therapy for mantle cell lymphoma patients.
Ongoing development efforts are evident, with over 750 CGT studies involving around 30,000 patients as of June 2020.
CGT drugs comprise approximately 12% of the pharmaceutical industry's clinical pipeline and at least 16% of the preclinical pipeline.
The demand for novel therapies, such as cancer and cardiovascular treatments, is driving research into cell-based solutions.
The Australian government launched the Cell Therapies Mission in November 2019, allocating US$ 102 million under the Medical Research Future Fund (MRFF) to incentivize stem cell research for new medicines.
Foster Innovation UK received GBP 267,000 in funding in September 2019 to support gel stabilization technology developed by Atelerix, with a focus on therapeutic applications.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
Novartis AG, Pharmicell, Osiris Therapeutics (Smith & Nephew), GlaxoSmithKline, Anterogen, IMFS, Stemedica Cell Technologies, NuVasive, BioNTech, Kolon TissueGene, JCR Pharmaceuticals, Cells for Cells, and Vericel Corporation.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ:
By Use Type
Clinical use
Therapeutic Area
Cell Type
Research Use
Byย Therapy Type
Allogenic Therapies
Autologous Therapies
By Region
North America
Latin America
Europe
APAC
MEA
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
In April 2019, Hitachi Chemical Co. Ltd. bought apceth Biopharma GmbH to expand its foothold in the contract development and manufacturing organization (CDMO) industry for gene and cell therapies production.
In June 2021, Charles River Laboratories acquired a cellular and gene therapy contract manufacturer-to-manufacturing capabilities through the acquisition of CDMO Cognate BioServices.
In August 2021,ย Thermo Fisher Scientific paid US$ 859.7 million for Henogen S.A., Novasep's viral vector production firm in Belgium. This purchase strengthens its position in the cell and gene therapy manufacturing therapeutic sector.
In July 2019,ย Thermo Fisher Scientific paid US$ 1.7 billion for Brammer Bio, a business that manufactures viral vectors for gene and cell treatments.
๐๐ซ๐๐๐ซ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=63273<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
Emergence of personalized cell therapies
Integration of artificial intelligence and machine learning in cell therapy development
Shift towards off-the-shelf cell therapies
Collaborations and partnerships among pharmaceutical companies and research institutes
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
The future of the cell therapy market appears promising, with continuous innovation and technological advancements driving the development of safer and more effective therapies. As research uncovers new applications and expands the understanding of cellular mechanisms, the landscape of healthcare is set to undergo transformative changes.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:
Understanding patient demographics and disease prevalence
Assessing regulatory landscapes across different regions
Analyzing competitive strategies and market positioning of key players
Monitoring advancements in cell manufacturing and therapy delivery techniques
Identifying emerging opportunities in niche therapeutic areas
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐:
๐๐๐ฎ๐ญ๐ ๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฎ๐ค๐๐ฆ๐ข๐ (๐๐๐) ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/03/15/2627542/0/en/Acute-Myeloid-Leukemia-AML-Biomarker-Testing-Market-to-Hit-USD-624-0-Mn-by-2031-Says-Transparency-Market-Research.html
๐๐ฎ๐ญ๐จ๐ฆ๐จ๐ญ๐ข๐ฏ๐ ๐๐๐๐ญ๐ก๐๐ซ ๐๐ฉ๐ก๐จ๐ฅ๐ฌ๐ญ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/03/15/2627439/0/en/Automotive-Leather-Upholstery-Market-to-Reach-US-7-0-Bn-by-2031-Europe-is-expected-to-dominate-the-worldwide-market-Transparency-Market-Research-Inc.html
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.comย ย ย
Email:ย sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Therapy Market to Surpass US$ 54.6 Bn by 2032, Latest Study by TMR here
News-ID: 3424160 • Views: โฆ
More Releases from Transparency Market Research
Autonomous Underwater Gliders Market Outlook 2034: Anticipated Growth from $1.7 โฆ
The global autonomous underwater gliders (AUGs) market was valued at US$ 1.7 billion in 2023. With a projected Compound Annual Growth Rate (CAGR) of 10.0% from 2024 to 2034, the market is expected to reach US$ 4.7 billion by the end of 2034. This growth is driven by increased investment in underwater research and a focus on enhancing maritime defense capabilities.
Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37259
Analyst Viewpoint
Investment in underwater researchโฆ
Biorefinery Market Outlook 2034: Industry to Expand from $148.4 Billion in 2023 โฆ
The global biorefinery market, valued at US$ 148.4 billion in 2023, is poised for substantial growth over the next decade. With an impressive Compound Annual Growth Rate (CAGR) of 8.0% from 2024 to 2034, the market is expected to reach US$ 360.5 billion by the end of 2034. This expansion is driven by a surge in demand for alternative fuel sources and the implementation of stringent regulations promoting renewable energy.
Downloadโฆ
Ball Mills Market Outlook 2034: Projected Growth from $6.9 Billion in 2023 to $1 โฆ
The global ball mills market, valued at US$ 6.9 billion in 2023, is projected to experience significant growth over the next decade. With an estimated Compound Annual Growth Rate (CAGR) of 5.3% from 2024 to 2034, the market is anticipated to reach US$ 13.4 billion by the end of 2034. This robust growth is driven by increased demand for functional inorganic materials and the expanding mining sector.
Download Sample Report Copyโฆ
Global Co-refining Market to Reach US$ 73.0 Bn by 2034, Growing at a CAGR of 6.0 โฆ
The global co-refining market was valued at US$ 39.7 billion in 2023 and is projected to grow at a CAGR of 6.0% from 2024 to 2034, reaching approximately US$ 73.0 billion by the end of 2034. This growth is driven by the increasing transition toward a low-carbon economy and the rise in the adoption of biofuels.
Analyst Viewpoint
The transition toward a low-carbon economy is significantly boosting co-refining market revenue. Countries andโฆ
More Releases for Cell
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect โฆ
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, typeโฆ
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends โฆ
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimerโs and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emergingโฆ
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste โฆ
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOYโฆ
Load Cell Market Key Player Analysis By Single Point Load Cell, Compression Load โฆ
The Load Cell Report consists of all the basic information regarding the Load Cell market. The all-inclusive report will aid users to understand the market current trends, industry growth drivers, share, analysis, size, production, forecast trends, supply, sales, demands, and many other aspects. The analysis was accomplished using an objective amalgamation of primary and secondary data including contributions from major participants in the market. The global Load Cell report isโฆ
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell โฆ
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports.
In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% betweenโฆ
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem โฆ
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports.
In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at aโฆ